home / stock / viri / viri quote
Last: | $0.456 |
---|---|
Change Percent: | -2.88% |
Open: | $0.455 |
Close: | $0.4695 |
High: | $0.4699 |
Low: | $0.45 |
Volume: | 45,081 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.456 | $0.455 | $0.4695 | $0.4699 | $0.45 | 45,081 | 04-29-2024 |
$0.4695 | $0.4609 | $0.4695 | $0.4749 | $0.44 | 39,799 | 04-26-2024 |
$0.4558 | $0.4378 | $0.4558 | $0.4679 | $0.4301 | 64,289 | 04-25-2024 |
$0.4252 | $0.419 | $0.4252 | $0.4747 | $0.419 | 197,618 | 04-24-2024 |
$0.431 | $0.4299 | $0.431 | $0.4455 | $0.415 | 61,255 | 04-23-2024 |
$0.4257 | $0.435 | $0.4257 | $0.4454 | $0.401 | 72,087 | 04-22-2024 |
$0.4355 | $0.459 | $0.4355 | $0.459 | $0.4354 | 63,468 | 04-19-2024 |
$0.4499 | $0.44 | $0.4499 | $0.45 | $0.421 | 62,794 | 04-18-2024 |
$0.4509 | $0.4639 | $0.4509 | $0.49 | $0.45 | 87,126 | 04-17-2024 |
$0.452 | $0.4569 | $0.452 | $0.49219 | $0.4401 | 167,856 | 04-16-2024 |
$0.471 | $0.5041 | $0.471 | $0.5292 | $0.47 | 166,327 | 04-15-2024 |
$0.512399 | $0.4631 | $0.512399 | $0.5278 | $0.4631 | 372,229 | 04-12-2024 |
$0.479899 | $0.4511 | $0.479899 | $0.50989 | $0.4444 | 39,496 | 04-11-2024 |
$0.465 | $0.46 | $0.465 | $0.4789 | $0.44 | 144,548 | 04-10-2024 |
$0.4644 | $0.4731 | $0.4644 | $0.5199 | $0.46 | 179,545 | 04-09-2024 |
$0.4505 | $0.4699 | $0.4505 | $0.4987 | $0.433 | 185,458 | 04-08-2024 |
$0.458 | $0.4899 | $0.458 | $0.4899 | $0.4404 | 246,674 | 04-05-2024 |
$0.481 | $0.497 | $0.481 | $0.5259 | $0.48 | 230,531 | 04-04-2024 |
$0.492 | $0.56 | $0.492 | $0.569399 | $0.49 | 214,041 | 04-03-2024 |
$0.54 | $0.58 | $0.54 | $0.58 | $0.4951 | 301,606 | 04-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Virios Therapeutics Inc. Company Name:
VIRI Stock Symbol:
NASDAQ Market:
- New patent would extend coverage and expand potential value of Virios’ antiviral pipeline globally – - Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses reactivation - - Published data indicates increased Epstein-Barr ...
ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) a...
ATLANTA, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FMȁ...